1. P12. Commissioning and evaluation of a new commercial small animal radiation research platform Xstrahl XenX irradiator. (December 2016) Authors: Adel, D.; Brengues, M.; Bedos, L.; Azria, D.; Fenoglietto, P.; Aillères, N. Journal: Physica medica Issue: Volume 32(2016)Supplement 4 Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 560PImpact of Immune response-associated gene polymorphisms on tumor response in rectal cancer patients treated with capecitabine +/- oxaliplatine and radiation in the ACCORD-12/PRODIGE-2 phase III trial. (18th September 2017) Authors: Valerie, B.; Mollevi, C.; Chaput, N.; Gourgou, S.; Azria, D.; Seitz, J.F.; Bigot, L.; Juzyna, B.; Miran, I.; Gérard, J-P.; Laurent-Puig, P. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy. (December 2018) Authors: Taourel, P.; Pages, E.; Millet, I.; Bourgier, C.; Rouanet, P.; Jacot, W.; Crochet, P.; Azria, D. Journal: Critical reviews in oncology/hematology Issue: Volume 132(2018) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Influence of medical contrast agent (Iomeron) on head and neck VMAT dose distributions. (November 2015) Authors: Pirault, N.; Boisselier, P.; Bedos, L.; Molinier, J.; Morel, A.; Siméon, S.; Aillères, N.; Azria, D.; Fenoglietto, P. Journal: Physica medica Issue: Volume 31(2015)Supplement 2 Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PD-0766 Impact of treatment and clinical factors on worsening of functional scales after prostate cancer RT. (August 2021) Authors: Cicchetti, A.; Joseph, N.; Choudhury, A.; Avuzzi, B.; Valdagni, R.; Rancati, T.; Seibold, P.; Chang-Claude, J.; Azria, D.; Vega, A.; Webb, A.; Talbot, C.; Elliott, R.; Sperk, E.; De Ruysscher, D.; Veldeman, L.; Lambrecht, M.; West, C. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PH-0656 Prediction of toxicity after prostate cancer RT: the value of a SNP-interaction polygenic risk score. (August 2021) Authors: Rancati, T.; Massi, M.; Franco, N.; Avuzzi, B.; Azria, D.; Choudhury, A.; Cicchetti, A.; Dirk, D.R.; Dunning, A.; Elliott, R.; Ieva, F.; Kerns, S.; Lambrecht, M.; Manzoni, A.; Paganoni, A.; Rosenstein, B.; Seibold, P.; Sperk, E.; Talbot, C.; Vega, A. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-1917 Circadian rhythm effects on radiotherapy toxicity. (August 2021) Authors: Talbot, C.; Webb, A.; Harper, E.; Azria, D.; Choudhury, A.; De Ruysscher, D.; Dunning, A.; Elliott, R.; Kerns, S.; Lambrecht, M.; Rancati, T.; Rosenstein, B.; Seibold, P.; Sperk, E.; Vega, A.; Veldeman, L.; Chang-Claude, J.; West, C.; Rattay, T.; Symonds, R.P. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PD-0925 An European cross-cultural analysis of worsening of functional scales in prostate cancer patients after RT. (August 2021) Authors: Cicchetti, A.; Joseph, N.; Seibold, P.; Avuzzi, B.; Valdagni, R.; Webb, A.; De Ruysscher, D.; Lambrecht, M.; Sperk, E.; Elliott, R.; Talbot, C.; Veldeman, L.; Chang-Claude, J.; Choudhury, A.; Vega, A.; Azria, D.; Rancati, T.; West, C. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC-0060 Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia. (August 2021) Authors: Clark, M.A.; Slotman, B.; Ozyar, E.; Kim, M.; Itami, J.; Tallet, A.; Debus, J.; Pfeffer, R.; Gentile, P.; Hama, Y.; Andratschke, N.; Azria, D.; Camilleri, P.; Belka, C.; Quivrin, M.; Kim, B.; Pedersen, A.; van Overeem Felter, M.; Young, K.; Kim, J.H. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-1014: Long time follow-up experience after IMRT for anal cancer: clinical outcomes and late toxicities. (April 2016) Authors: De Meric de Bellefon, M.; Fenoglietto, P.; Azria, D.; Llacer-Moscardo, C.; Riou, O.; Pirault, N.; Combettes, E.; Aillères, N.; Castan, F.; Lemanski, C. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗